👉 Shop GLP-1 Support – 20% off with Epoch Health Offer

References

CDC National Center for Health Statistics, 2023
CDC National Diabetes Statistics Report, 2022
IQVIA Institute for Human Data Science, U.S. Medication Trends 2023
Ribeiro CB, Ramos FM, Manthey JA, Cesar TB. Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition. Phytother Res. 2019;33(7):1921-1933. https://pubmed.ncbi.nlm.nih.gov/30919998
Cesar TB, Ramos FMM, Ribeiro CB. Eriomin® reduces hyperglycemia by increasing GLP-1 and downregulating systemic inflammation. J Med Food. 2022;25(11):1050-1058. https://pubmed.ncbi.nlm.nih.gov/36384444
Ramos FM, Ribeiro CB, Cesar TB, et al. Eriomin® attenuates prediabetes intestinal dysbiosis. Food Sci Nutr. 2023. https://pubmed.ncbi.nlm.nih.gov/37415644
Wang Y, Liu S, Yang Z, et al. Mulberry leaf extract reduces postprandial glycemia in healthy adults. J Diet Suppl. 2017;14(6):650-661. https://pubmed.ncbi.nlm.nih.gov/28914546
Zhang Y, et al. Mulberry leaf extract for glucose metabolism in prediabetic adults. J Med Food. 2021;24(1):35-41. https://pubmed.ncbi.nlm.nih.gov/32811282
Cardile V, et al. Moro orange extract and weight management: a randomized clinical evaluation. Nat Prod Res. 2015;29(6):518-522. https://pubmed.ncbi.nlm.nih.gov/25280038
Taghavi M, et al. Feijoa sellowiana supplementation in type 2 diabetics: effect on glycemic control and lipids. Int J Endocrinol Metab. 2012;10(2):497–503. https://ijem.sbmu.ac.ir/article_1223.html
Derosa G, et al. Abscisic acid treatment in prediabetics: effects on glyco-metabolic markers. Nutrients. 2020;12(10):2931. https://pubmed.ncbi.nlm.nih.gov/32987917
American Society for Dermatologic Surgery. “Ozempic Face” and Aesthetic Concerns with Rapid Weight Loss. 2023. https://www.asds.net/Blog/Post/ozempic-face-and-weight-loss
FDA Prescribing Information for Ozempic and Wegovy
Lee CJ, et al. Pancreatitis associated with GLP-1 receptor agonists. Diabetes Metab Syndr Obes. 2019. https://pubmed.ncbi.nlm.nih.gov/31410036
Faillie JL, et al. Gallbladder-related events associated with GLP-1 agonists. JAMA Intern Med. 2016. https://pubmed.ncbi.nlm.nih.gov/27842167
Egan AG, et al. FDA perspective on GLP-1 kidney risks. N Engl J Med. 2011. https://pubmed.ncbi.nlm.nih.gov/21776413
FDA. Update on Suicidal Thoughts and GLP-1 Drugs. July 2023. https://www.fda.gov/drugs/drug-safety-and-availability/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type
Zhang Y, et al. GLP-1 and bone metabolism: a review. Front Endocrinol. 2022. https://pubmed.ncbi.nlm.nih.gov/35401626

Disclaimers:

†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

GLP-1 Up does not contain GLP-1 or synthetic GLP-1 and is not a GLP-1 agonist drug. GLP-1 Up is not a weight loss supplement. The product is formulated to support healthy weight management.†

How to Activate GLP-1 Naturally and Reset Your Metabolism Without Drugs

Mix, Sip, Thrive: The Hottest Supplement Powders From Expo West 2026

Scientists Discover How Dirty Your Toothbrush REALLY Is And A Brilliant Way to Clean It

Why 1 Million+ People Chose These Hearing Aids Over the More Expensive Options